Presented in an oral session at the 67th American Society of Hematology Annual Meeting & Exposition ...

Officials across the East End are grappling with how to encourage new infrastructure while preserving a pastoral aesthetic.

An in vivo chimeric antigen receptor T-cell therapy administered without lymphodepletion exhibited activity among patients with advanced multiple myeloma, according to findings presented at ASH Annual ...

Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational ...

This article was reviewed by Felix Gussone, MD. How to Read Blood Test Results: What “Normal” Really Means for Your Health ...

The Food and Drug Administration (FDA) has approved Breyanzi ® (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) ...

The researchers argue that their findings, published in Scientific Reports, could help clinicians anticipate which patients ...

The addition of ianalumab to eltrombopag significantly improved outcomes for patients with pretreated primary immune ...

Research from Umeå University paves the way for a quantitative data analysis method to study the cell division process in individual cells. The improved resolution will promote advanced cell analysis ...

Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive ...

Modern biology runs on precision, yet so much of the daily lab workflow remains stubbornly manual. Even today, one of ...